T

Trajan Group Holdings Ltd
ASX:TRJ

Watchlist Manager
Trajan Group Holdings Ltd
ASX:TRJ
Watchlist
Price: 1.095 AUD 7.35% Market Closed
Market Cap: 166.7m AUD
Have any thoughts about
Trajan Group Holdings Ltd?
Write Note

Net Margin
Trajan Group Holdings Ltd

-16.3%
Current
-2%
Average
0.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-16.3%
=
Net Income
-25.3m
/
Revenue
155m

Net Margin Across Competitors

Country AU
Market Cap 166.7m AUD
Net Margin
-16%
Country US
Market Cap 1.2T USD
Net Margin
9%
Country US
Market Cap 202.3B USD
Net Margin
14%
Country US
Market Cap 166.6B USD
Net Margin
18%
Country KR
Market Cap 66.5T KRW
Net Margin
24%
Country CH
Market Cap 38.4B CHF
Net Margin
9%
Country US
Market Cap 38.8B USD
Net Margin
20%
Country US
Market Cap 36.3B USD
Net Margin
9%
Country US
Market Cap 27B USD
Net Margin
21%
Country US
Market Cap 24.1B USD
Net Margin
17%
Country CN
Market Cap 163.2B CNY
Net Margin
21%
No Stocks Found

Trajan Group Holdings Ltd
Glance View

Market Cap
166.7m AUD
Industry
Life Sciences Tools & Services

Trajan Group Holdings Ltd. engages in the designing, manufacturing and supply of products and solutions that enhance scientific measurement. The firm is developing and manufacturing analytical science instruments, devices and solutions used in the analysis of biological, food and environmental samples. The firm is focused on serving life science, biopharmaceutical, and analytical companies in the United States, Australia, Europe, and Asia. The firm is operating in two segments, which includes Analytical Products and Life Science Solutions. Its Analytical Products include Metal syringes, Gas tight syringes, eVol, liquid extraction (uLLE), Electrokinetic extraction (EkE), Ferrules, Microfluidics, Emitter tips, Septa and caps and Porous polymer monoliths. Its Life Science Solutions include Dispensing syringes, Microscope slides, Coverslips, Slide and cassette storage, Liquid powder dispensing, Infusion automation, hemaPEN, Microbiopsy and Hummingbird. The company also offers micro-biopsy device for skin sampling, including Mitra device.

TRJ Intrinsic Value
2.868 AUD
Undervaluation 62%
Intrinsic Value
Price
T

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-16.3%
=
Net Income
-25.3m
/
Revenue
155m
What is the Net Margin of Trajan Group Holdings Ltd?

Based on Trajan Group Holdings Ltd's most recent financial statements, the company has Net Margin of -16.3%.